alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Clinical trials

Clinical trials

Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 6,676–6,700 of 7,816 matching trials · page 268 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
Gray Matters Alzheimer's Disease Prevention Intervention
NCT02290912
Health education program 		NA
other		 COMPLETED 146 Utah State University
OTHER		 2015-12-03
The Dementia Quality of Life Scale for Older Family Carers (DQoL-OC) Study
NCT02463734
Runs in: United Kingdom · 14 sites 		NA
other		 UNKNOWN 300 University of Nottingham
OTHER		 2015-12-03
Improving Mood and Behavior in Assisted Living Residents Through Skills Training for Their Caregivers
NCT00255866
Skills training for the care of dementia patients
Runs in: United States · 2 sites 		PHASE2|PHASE3
other		 COMPLETED 90 University of Washington
OTHER		 2015-12-02
Facilitating Caregiver Adaptation to Patient Institutionalization
NCT01194128
Psychoeducational Support; Information only control group
Runs in: United States · 1 site 		PHASE3
other		 COMPLETED 217 University of Pittsburgh
OTHER		 2015-12-02
Patients With Behavioural Symptoms and Hospitalized in Cognitive and Behavioural Units
NCT01901263
patients with alzheimer's disease
Runs in: France · 3 sites 		NA
other		 COMPLETED 306 Centre Hospitalier Universitaire de Saint Etienne
OTHER		 2015-12-02
An Exploratory Clinical Trial in Early Stage Huntington's Disease Patients With SEN0014196
NCT01485952
SEN0014196 (Low Dose); SEN0014196 (High Dose); Placebo
Runs in: Germany · 1 site 		PHASE1
other		 COMPLETED 55 Siena Biotech S.p.A.
INDUSTRY		 2015-11-25
A Phase II Safety and Tolerability Study With SEN0014196
NCT01521585
SEN0014196; SEN0014196; Placebo
Runs in: Germany · 1 site 		PHASE2
other		 COMPLETED 144 Siena Biotech S.p.A.
INDUSTRY		 2015-11-25
A Study to Assess Effect of JNJ-54861911 on Pharmacokinetics of Cocktail Representatives for Cytochrome P450 (CYP) 3A4, CYP2B6, CYP2C9, and CYP1A2 Substrates
NCT02211079
JNJ-54861911; Caffeine; Midazolam; Tolbutamide
Runs in: Netherlands · 1 site 		PHASE1
other		 COMPLETED 16 Janssen Research & Development, LLC
INDUSTRY		 2015-11-24
Quetiapine for Delirium Prophylaxis in High-risk Critically Ill Patients
NCT02612948
Quetiapine
Runs in: United States · 1 site 		PHASE4
other		 COMPLETED 82 University of Tennessee Graduate School of Medicine
OTHER		 2015-11-24
Low-Dose Opiate Therapy for Discomfort in Dementia (L-DOT)
NCT00385684
hydrocodone/APAP w placebo PRN; hydrocodone/APAP; placebo with hydr...
Runs in: United States · 3 sites 		PHASE4
other		 COMPLETED 11 VA Office of Research and Development
OTHER_GOV		 2015-11-20
Methylphenidate for Apathy in Alzheimer's Dementia: A Controlled Study
NCT00495820
Methylphenidate; Placebo
Runs in: United States · 1 site 		PHASE4
other		 COMPLETED 60 VA Office of Research and Development
OTHER_GOV		 2015-11-20
Effects of Antimuscarinics on Cognition in Spinal Cord Injury
NCT01600404
antimuscarinic treatment
Runs in: Switzerland · 1 site 		NA
other		 COMPLETED 32 Swiss Paraplegic Research, Nottwil
NETWORK		 2015-11-17
Safety Study of MT-4666 in Subjects With Alzheimer's Disease
NCT02327182
MT-4666
Runs in: Japan · 1 site 		PHASE3
other		 TERMINATED 117 Tanabe Pharma Corporation
INDUSTRY		 2015-11-13
Double-blind, Placebo-controlled Study of Oral Dimebon in Subjects With Mild to Moderate Alzheimer's Disease
NCT00377715
Dimebon; Placebo
Runs in: Russia · 1 site 		PHASE2
other		 COMPLETED 183 Medivation, Inc.
INDUSTRY		 2015-11-11
Safety and Tolerability of Dimebon in Patients on Memantine, and Memantine Plus Donepezil
NCT00829816
Dimebon; Placebo
Runs in: United States · 4 sites 		PHASE1
symptomatic-cholinergic		 COMPLETED 46 Medivation, Inc.
INDUSTRY		 2015-11-10
Pharmacokinetic Properties of Idalopirdine (Lu AE58054) in Subjects With and Without Impaired Kidney Function
NCT02340195
Idalopirdine (Lu AE58054) 60 mg
Runs in: Germany · 1 site 		PHASE1
other		 COMPLETED 16 H. Lundbeck A/S
INDUSTRY		 2015-11-09
Placebo-Controlled Crossover Study to Evaluate Donepezil and MK-3134 for Reversal of Cognitive Impairment Associated With Scopolamine Administration (3134-005)(COMPLETED)
NCT01181310
A: Placebo to match Donepezil and MK-3134 + Placebo to match Scopol... 		PHASE1
symptomatic-cholinergic		 COMPLETED 31 Merck Sharp & Dohme LLC
INDUSTRY		 2015-11-06
Safety, Radiation Dosimetry, Biokinetics, and Effectiveness of [18F]MK3328 (MK-3328-001)
NCT00954538
[18F]MK-3328 		PHASE1
other		 COMPLETED 19 Merck Sharp & Dohme LLC
INDUSTRY		 2015-11-03
Safety, Tolerability, and Efficacy of Donepezil (Aricept) in Parkinson' s Disease (PD) Patients With Dementia
NCT01327859
Prior Donepezil 5mg; Prior Donzepezil 10mg; Prior Placebo
Runs in: United Kingdom · 1 site 		PHASE3
symptomatic-cholinergic		 COMPLETED 357 Eisai Inc.
INDUSTRY		 2015-11-03
EEG (Electroencephalogram) Platform Standardization in Healthy Male Subjects (3134-010)
NCT01110616
MK3134; Comparator: Lorazepam; Comparator: Placebo 		PHASE1
other		 COMPLETED 25 Merck Sharp & Dohme LLC
INDUSTRY		 2015-11-02
Identification of Biomarkers Sensitive to Disease Progression in Patients With Mild Cognitive Impairment
NCT01425957
Lumbar puncture
Runs in: France; Germany; Greece; Italy; Netherlands; Spain · 13 sites 		NA
other		 COMPLETED 229 Qualissima
OTHER		 2015-11-02
Cartoon Distraction and Parental Presence on Anxiety in Pediatric Anesthesia
NCT02027844
Cartoon; parental presence
Runs in: South Korea · 1 site 		NA
other		 COMPLETED 117 Yeungnam University College of Medicine
OTHER		 2015-11-02
Cerebrolysin Compared to Donepezil in Patients With Mild to Moderate Dementia of Alzheimer's Type (DAT)
NCT01822951
Cerebrolysin; Donepezil
Runs in: Austria · 1 site 		PHASE4
symptomatic-cholinergic		 WITHDRAWN 0 Ever Neuro Pharma GmbH
INDUSTRY		 2015-10-26
Memory Training in Patients With Amnestic Mild Cognitive Impairment
NCT01978353
Memory Training; Psychoeducation
Runs in: Brazil · 1 site 		NA
other		 COMPLETED 30 University of Sao Paulo General Hospital
OTHER		 2015-10-26
Early-onset and Late-onset Sporadic Alzheimer's Disease (AD)
NCT00987090
Clinic and neuropsychologic evaluation; MRI; PET; Apolipoprotein E ...
Runs in: France · 1 site 		NA
other		 UNKNOWN 240 Assistance Publique Hopitaux De Marseille
OTHER		 2015-10-23

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →